Lynx1 Capital Management LP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dorado
SEC filing record 1 source field available
Fiscal year end
31 December
Lynx1 Capital Management LP has filed 126 SEC EDGAR filings since 14 Feb 2022

SEC filing history

Showing 76-100 of 126 matching filings.

Per page
25
Current page
4
SC 13G/A

PIERIS PHARMACEUTICALS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

GH RESEARCH PLC

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

BIONOMICS LIMITED

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

C4 THERAPEUTICS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

STOKE THERAPEUTICS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
N-PX File 028-22151

N-PX filing

Filing date
10 Oct 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR/A File 028-22151

13F-HR/A filing

Filing date
19 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PASSAGE BIO, INC.

Filing date
09 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-39231

3 filing

Filing date
09 Aug 2024
Reporting date
07 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR/A File 028-22151

13F-HR/A filing

Filing date
30 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40603

4 filing

Filing date
23 Apr 2024
Reporting date
19 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

IBIO, INC.

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PASSAGE BIO, INC.

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

GH RESEARCH PLC

Filing date
16 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Feb 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ALPINE IMMUNE SCIENCES, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

KINNATE BIOPHARMA INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PASSAGE BIO, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

C4 THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

STOKE THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

CABALETTA BIO, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PIERIS PHARMACEUTICALS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

NEUROGENE INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .